Olmesartan Medoxomil 20/5 mg

Adult dose

Olmesartan Medoxomil: The recommended initial dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled, the dose may be increased to 20 mg once daily, with a maximum dose of 40 mg once daily. The antihypertensive effect usually appears within 2 weeks after starting treatment, with maximum effect observed around 8 weeks. This medication may be combined with thiazide diuretics such as hydrochlorothiazide.

Child dose

Olmesartan Medoxomil: Safety and efficacy have not been established in pediatric patients under 18 years of age.

This medication can cause serious damage to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Persons who are allergic to this medication or its components, pregnant or potentially pregnant women, and breastfeeding individuals should not take this medication. Patients with severely impaired kidney function, those on dialysis, patients with severe liver impairment, patients with biliary obstruction, and those with muscle diseases should not use this medication. This medication contains lactose, so individuals with lactose intolerance or related genetic conditions should avoid it. Patients with reduced blood volume or those on high-dose diuretics should be cautious as hypotension may occur, and their condition should be well monitored in the early stages of treatment. While taking this medication, regular monitoring of blood pressure, kidney function, blood potassium levels, etc., is necessary to ensure there are no abnormalities. This medication may cause myalgia or muscle weakness, and rarely, it may lead to rhabdomyolysis, so consultation with a doctor should be sought immediately if there is muscle pain or weakness. Elderly patients or those with a history of liver disease should have their liver function tested regularly and should avoid alcohol consumption. This medication may interact with other drugs, so it is essential to inform healthcare providers if other medications are being taken. Dizziness or drowsiness may occur during treatment, so caution should be exercised while driving or handling dangerous machinery. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should use appropriate contraception. Safety and efficacy in children or adolescents under 18 have not been established. In cases of overdose, hypotension or arrhythmia may occur, so immediate medical attention is necessary, and there is no specific antidote. This medication should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, fever with severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory distress with cough and fever, yellowing of the skin or eyes (jaundice), generalized extreme fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• decreased sensation
• drowsiness
• gastroesophageal reflux disease
• constipation
• dental caries
• dyspepsia
• gastric ulcer
• gastritis

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

White or slightly yellow round film-coated tablets

Package unit

30 tablets/box [30 tablets (10 tablets/Alu-Alu) X 3]